Australia markets open in 5 hours 46 minutes

Nuo Therapeutics, Inc. (AURX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.80000.0000 (0.00%)
As of 12:21PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 35.39M
Enterprise value 34.72M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)55.32
Price/book (mrq)34.06
Enterprise value/revenue 57.06
Enterprise value/EBITDA -11.34

Trading information

Stock price history

Beta (5Y monthly) -678.98
52-week change 3-66.67%
S&P500 52-week change 323.10%
52-week high 32.4000
52-week low 30.4010
50-day moving average 30.8377
200-day moving average 30.7346

Share statistics

Avg vol (3-month) 32.08k
Avg vol (10-day) 35k
Shares outstanding 544.24M
Implied shares outstanding 644.24M
Float 818.01M
% held by insiders 160.69%
% held by institutions 14.95%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-330.99%

Management effectiveness

Return on assets (ttm)-80.41%
Return on equity (ttm)-196.34%

Income statement

Revenue (ttm)608.52k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)166.20%
Gross profit (ttm)N/A
EBITDA -3.15M
Net income avi to common (ttm)-3.17M
Diluted EPS (ttm)-0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)928.68k
Total cash per share (mrq)0.02
Total debt (mrq)255.59k
Total debt/equity (mrq)24.60%
Current ratio (mrq)2.32
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-3.17M
Levered free cash flow (ttm)-1.85M